demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
interferon
IFN beta-1a SOLIDARITY ...
high-dose IFN beta-1a Darazam
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co Li
SNG001 inhaled interferon beta Synairgen SG016
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann

0 studies excluded by filtering options 0